Success of the vaccination campaign against meningitis in the region’s schools

This year, a meningococcal vaccination campaign (targeting serogroups A, B, C, W, and Y) was successfully implemented in secondary schools in Montérégie-Ouest. Initially focusing on students in secondary grades 4 and 5 for the serogroup C vaccine, the campaign exceeded expectations, achieving an 80% participation rate, surpassing the Public Health Department’s projected 70%.

Progress

Vaccination clinics were held in all 20 public and private schools within the region, successfully vaccinating over 7,650 young students. This represents 80% of the targeted student population, significantly exceeding the set objectives. Some schools even achieved an impressive vaccination rate of over 91%.

The success of this campaign was due to the remarkable collaboration between school services and local service point staff. Nurses, school health nurse assistants, point-of-service injectors, service assistants, and administrative officers all contributed to the smooth operation of the clinics. Their efforts ensured accurate recording of vaccination data in the provincial computerized infectious diseases system.

Next steps

For those who were unable to get vaccinated during this school campaign but meet the eligibility criteria, a catch-up session will be offered starting in spring 2025, according to the regional organization of vaccination services.

For more information about the meningococcal vaccine and eligibility criteria for catch-up sessions, visit the dedicated page of the Quebec Ministry of Health and Social Services here.

Congratulations to all the teams for their dedication and efficiency!

Meningococcal Vaccination Campaign a Success in Montérégie-Ouest

The meningococcal vaccination campaign, targeting secondary schools in Montérégie-Ouest, has wrapped up with exceptional results. The campaign, focusing on the vaccination of students against serogroups A, B, C, W and Y, exceeded all expectations and achieved a remarkable participation rate of 80%, surpassing the initial target of 70% set by the Public Health Department.

A Collaborative Effort for Enhanced Student Health

The successful campaign involved a multifaceted collaboration between school services and local service point personnel. Nurses, school health nurse assistants, point-of-service injectors, service assistants, and administrative officers worked diligently, ensuring the smooth operation of the vaccination clinics. Their efforts extended to accurately recording vaccination data within the provincial computerized infectious diseases system.

Reaching Out to a Large Student Population

Vaccination clinics were established throughout the territory, encompassing all 20 public and private schools. These clinics played a crucial role in administering the meningococcal vaccine to a remarkable number of young students, exceeding 7,650 individuals. This impressive figure translates to an 80% participation rate among the targeted student population. Notably, certain schools achieved even higher vaccination rates, surpassing 91%.

A Vital Step in Protecting Young People

The meningococcal vaccine is essential in safeguarding individuals from contracting a potentially life-threatening bacterial infection. Meningococcal disease can manifest as meningitis (inflammation of the membranes surrounding the brain and spinal cord) or septicaemia (blood poisoning). While rare, it is a serious condition that requires prompt medical attention to prevent complications. Through vaccination, students are granted protection against these serious health risks.

Moving Forward: Catch-Up Sessions for Eligible Individuals

Recognizing that some individuals may have missed the vaccination opportunity during the school campaign, a dedicated catch-up session is scheduled for spring 2025. This session will be organized on a regional basis, allowing eligible individuals who missed the initial campaign to receive their vaccination.

Related Articles:  [칼럼] “From fracture to death?”… Why hip fractures are dangerous

The eligibility criteria for catch-up sessions will be determined according to guidelines set forth by the Quebec Ministry of Health and Social Services. For detailed information regarding the meningococcal vaccine, including eligibility criteria for catch-up sessions, you can visit the dedicated page on the official website of the Quebec Ministry of Health and Social Services: https://www.quebec.ca/sante/conseils-et-prevention/vaccination/vaccins-meningocoques.

Celebrating Success and Recognising Dedication

This vaccination campaign was a resounding success, achieved through the tireless efforts of numerous dedicated individuals. The commitment and efficiency demonstrated by all involved teams are highly commendable. Congratulations to all who participated in this vital initiative, ensuring the well-being and protection of our youth.

**Images:**


Frequently Asked Questions

What is meningococcal disease?

Meningococcal disease is a bacterial infection caused by the Neisseria meningitidis bacteria, which can lead to meningitis (inflammation of the membranes around the brain and spinal cord) or septicaemia (blood poisoning).

Who is at risk for meningococcal disease?

While anyone can contract meningococcal disease, infants, young children, and adolescents are at higher risk. Additionally, individuals living in crowded environments, such as dorms, military barracks, and prisons, are considered more susceptible.

What are the symptoms of meningococcal disease?

Symptoms of meningococcal disease can vary depending on the type of infection. Common symptoms include:

  • Fever
  • Stiff neck
  • Headache
  • Vomiting
  • Sensitivity to light
  • Rash
  • Confusion
  • Seizures

If you or someone you know experiences these symptoms, it is crucial to seek immediate medical attention.

How is meningococcal disease treated?

Meningococcal disease is treated with antibiotics. Early diagnosis and treatment are crucial for improving outcomes.

What are the benefits of meningococcal vaccination?

Vaccination against meningococcal disease offers significant benefits, including:

  • Reduces the risk of developing meningococcal disease
  • Protects against serious complications, such as meningitis, sepsis, and death
  • Contributes to herd immunity, which protects those who cannot be vaccinated

Where can I get more information about meningococcal vaccination?

For comprehensive information about meningococcal disease, including vaccination options and eligibility criteria, consult the official website of the Quebec Ministry of Health and Social Services: https://www.quebec.ca/sante/conseils-et-prevention/vaccination/vaccins-meningocoques.

You can also reach out to your local public health department for guidance and assistance.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.